Baird Financial Group, Inc. Charles River Laboratories International, Inc. Transaction History
Baird Financial Group, Inc.
- $54.4 Billion
- Q2 2025
A detailed history of Baird Financial Group, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Baird Financial Group, Inc. holds 2,147 shares of CRL stock, worth $366,879. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,147
Previous 2,568
16.39%
Holding current value
$366,879
Previous $386,000
15.8%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CRL
# of Institutions
639Shares Held
53.3MCall Options Held
1.42MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA5.81MShares$993 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$869 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.77MShares$644 Million0.11% of portfolio
-
Allspring Global Investments Holdings, LLC2.18MShares$372 Million0.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$318 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.69B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...